Drugs

News and Updates about the regulations in Drugs and Pharma

AstraZeneca and Merck Report OlympiA Phase 3 Trial Finds Lynparza Significantly Enhances Survival in Early Stage Breast Cancer

AstraZeneca in collaboration with Merck—recognized as MSD outside the US and Canada—has unveiled enduring data from the OlympiA phase 3 trial, demonstrating that Lynparza (olaparib) achieves long-lasting, meaningful clinical improvements in overall survival (OS), invasive disease-free survival (IDFS), and distant […]

AstraZeneca and Merck Report OlympiA Phase 3 Trial Finds Lynparza Significantly Enhances Survival in Early Stage Breast Cancer Read More »

NEC Bio Unveils Encouraging Interim Outcomes from Phase 1 Study of AI-Powered Oral Cancer Vaccine, NECVAX-NEO1, at 2024 ESMO Conference

NEC Bio Therapeutics, a company at the forefront of clinical strategy and trial management in oncology, has showcased impressive interim outcomes from a 24-week phase 1 trial of NECVAX-NEO1. This orally administered cancer vaccine, designed to work in tandem with

NEC Bio Unveils Encouraging Interim Outcomes from Phase 1 Study of AI-Powered Oral Cancer Vaccine, NECVAX-NEO1, at 2024 ESMO Conference Read More »

Asahi Kasei Pharma Expands Global Presence with Exclusive Anti-CX3CR1 Antibody Licensing Deal

Asahi Kasei Pharma has advanced its evolution into a global specialty pharmaceuticals leader through a new licensing deal with Chiome Bioscience for a humanized anti-CX3CR1 antibody. This collaboration exemplifies the Open Innovation initiative at Asahi Kasei Pharma, which focuses on

Asahi Kasei Pharma Expands Global Presence with Exclusive Anti-CX3CR1 Antibody Licensing Deal Read More »

New Pharmacist Reference Guide Enhances Self-Care Support for Universal Health Coverage Day

The International Pharmaceutical Federation (FIP) has unveiled a comprehensive ‘Knowledge and Skills Reference Guide for Pharmacists in Self-Care Support,’ coinciding with the annual observance of Universal Health Coverage Day on December 12. “Self-care embodies the capacity of individuals and communities

New Pharmacist Reference Guide Enhances Self-Care Support for Universal Health Coverage Day Read More »

CDSCO Grants Approval for Afrezza Inhalation Powder in India by MannKind and Cipla

MannKind Corporation and Cipla Ltd. Celebrate Approval of Inhaled Insulin Afrezza by CDSCO in India MannKind Corporation, renowned for developing cutting-edge inhaled therapeutic products and devices tailored for patients with endocrine and rare lung ailments, alongside Cipla Ltd., have announced

CDSCO Grants Approval for Afrezza Inhalation Powder in India by MannKind and Cipla Read More »

Healthcare Authority Revises Medical Devices Regulations to Allocate Testing Facilities for Gloves

The Union health ministry has revised the Medical Devices Regulations (MDR), 2017 to appoint three testing laboratories in the nation for the evaluation of surgical and medical examination gloves. Additionally, alterations have been made to pertinent rules under the MDR,

Healthcare Authority Revises Medical Devices Regulations to Allocate Testing Facilities for Gloves Read More »